Breastfeeding Duration and Anogenital Distance in 2-Year-Old Infants

Juan Antonio Ortega-García1, Henry Andrés Olano-Soler1, Ana Martínez-Álvarez1

  • 11 Pediatric Environmental Health Speciality Unit, Department of Pediatrics, Institute of Biomedical Research, IMIB-Arrixaca, Hospital Clinical University Virgen of Arrixaca, Murcia, Spain .

Insights

Longer breastfeeding duration is linked to increased anogenital distance (AGD) in boys. Early introduction of infant formula may shorten AGD in male infants, highlighting the importance of breastfeeding for infant development.

Area of Science:

  • Environmental Health
  • Pediatrics
  • Endocrinology

Background:

  • Anogenital distance (AGD) is an anthropometric marker influenced by prenatal and early-life androgen exposure.
  • Endocrine-disrupting chemicals like phthalates are linked to reduced AGD in boys.
  • Limited research exists on phthalate levels in breast milk and infant formula.

Purpose of the Study:

  • To investigate the association between breastfeeding duration and anogenital distance (AGD) in infants.
  • To explore potential impacts of breastfeeding on male infant development markers.

Main Methods:

  • The MALAMA study followed 430 mother-child pairs from birth to 2 years.
  • AGD measurements were taken in a subsample of 71 boys and 49 girls at age 2.
  • Statistical analyses included correlations and linear regressions between AGD and breastfeeding duration.

Main Results:

  • Breastfeeding duration, particularly full breastfeeding (FB), showed a significant positive correlation with AGD in boys (p < 0.05).
  • Anoscrotal distance (AGDAS) and anopenile distance (AGDAP) were positively associated with full breastfeeding.

Conclusions:

  • A positive correlation exists between anogenital distance in male infants and breastfeeding duration.
  • Early introduction of infant formula may be associated with reduced AGD in boys.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
645
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
89.7K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
692
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship01:14

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
80
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360